List of Tables
Table 1. Global Antibiotics for Dogs and Cats Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antibiotics for Dogs and Cats Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antibiotics for Dogs and Cats Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antibiotics for Dogs and Cats Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Antibiotics for Dogs and Cats Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antibiotics for Dogs and Cats Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antibiotics for Dogs and Cats Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antibiotics for Dogs and Cats, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antibiotics for Dogs and Cats, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antibiotics for Dogs and Cats, Product Type & Application
Table 12. Global Key Manufacturers of Antibiotics for Dogs and Cats, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antibiotics for Dogs and Cats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotics for Dogs and Cats as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antibiotics for Dogs and Cats Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antibiotics for Dogs and Cats Sales by Region (2020-2025) & (K Units)
Table 18. Global Antibiotics for Dogs and Cats Sales Market Share by Region (2020-2025)
Table 19. Global Antibiotics for Dogs and Cats Sales by Region (2026-2031) & (K Units)
Table 20. Global Antibiotics for Dogs and Cats Sales Market Share by Region (2026-2031)
Table 21. Global Antibiotics for Dogs and Cats Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antibiotics for Dogs and Cats Revenue Market Share by Region (2020-2025)
Table 23. Global Antibiotics for Dogs and Cats Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antibiotics for Dogs and Cats Revenue Market Share by Region (2026-2031)
Table 25. North America Antibiotics for Dogs and Cats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antibiotics for Dogs and Cats Sales by Country (2020-2025) & (K Units)
Table 27. North America Antibiotics for Dogs and Cats Sales by Country (2026-2031) & (K Units)
Table 28. North America Antibiotics for Dogs and Cats Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antibiotics for Dogs and Cats Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antibiotics for Dogs and Cats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antibiotics for Dogs and Cats Sales by Country (2020-2025) & (K Units)
Table 32. Europe Antibiotics for Dogs and Cats Sales by Country (2026-2031) & (K Units)
Table 33. Europe Antibiotics for Dogs and Cats Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antibiotics for Dogs and Cats Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antibiotics for Dogs and Cats Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Antibiotics for Dogs and Cats Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antibiotics for Dogs and Cats Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibiotics for Dogs and Cats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antibiotics for Dogs and Cats Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Antibiotics for Dogs and Cats Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Antibiotics for Dogs and Cats Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antibiotics for Dogs and Cats Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antibiotics for Dogs and Cats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antibiotics for Dogs and Cats Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Antibiotics for Dogs and Cats Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Antibiotics for Dogs and Cats Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antibiotics for Dogs and Cats Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antibiotics for Dogs and Cats Sales (K Units) by Type (2020-2025)
Table 51. Global Antibiotics for Dogs and Cats Sales (K Units) by Type (2026-2031)
Table 52. Global Antibiotics for Dogs and Cats Sales Market Share by Type (2020-2025)
Table 53. Global Antibiotics for Dogs and Cats Sales Market Share by Type (2026-2031)
Table 54. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2020-2025)
Table 57. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2026-2031)
Table 58. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2020-2025)
Table 59. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2026-2031)
Table 60. Global Antibiotics for Dogs and Cats Sales (K Units) by Application (2020-2025)
Table 61. Global Antibiotics for Dogs and Cats Sales (K Units) by Application (2026-2031)
Table 62. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2020-2025)
Table 63. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2026-2031)
Table 64. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antibiotics for Dogs and Cats Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2020-2025)
Table 67. Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2026-2031)
Table 68. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2020-2025)
Table 69. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2026-2031)
Table 70. Huvepharma Company Information
Table 71. Huvepharma Description and Business Overview
Table 72. Huvepharma Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Huvepharma Antibiotics for Dogs and Cats Product
Table 74. Huvepharma Recent Developments/Updates
Table 75. Merck & Co Company Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck & Co Antibiotics for Dogs and Cats Product
Table 79. Merck & Co Recent Developments/Updates
Table 80. Ceva Animal Health Company Information
Table 81. Ceva Animal Health Description and Business Overview
Table 82. Ceva Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Ceva Animal Health Antibiotics for Dogs and Cats Product
Table 84. Ceva Animal Health Recent Developments/Updates
Table 85. Zoetis Company Information
Table 86. Zoetis Description and Business Overview
Table 87. Zoetis Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Zoetis Antibiotics for Dogs and Cats Product
Table 89. Zoetis Recent Developments/Updates
Table 90. Crystal Pharma Company Information
Table 91. Crystal Pharma Description and Business Overview
Table 92. Crystal Pharma Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Crystal Pharma Antibiotics for Dogs and Cats Product
Table 94. Crystal Pharma Recent Developments/Updates
Table 95. Afrivet Company Information
Table 96. Afrivet Description and Business Overview
Table 97. Afrivet Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Afrivet Antibiotics for Dogs and Cats Product
Table 99. Afrivet Recent Developments/Updates
Table 100. Elanco Company Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Elanco Antibiotics for Dogs and Cats Product
Table 104. Elanco Recent Developments/Updates
Table 105. Merck Animal Health Company Information
Table 106. Merck Animal Health Description and Business Overview
Table 107. Merck Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Merck Animal Health Antibiotics for Dogs and Cats Product
Table 109. Merck Animal Health Recent Developments/Updates
Table 110. Merial Company Information
Table 111. Merial Description and Business Overview
Table 112. Merial Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merial Antibiotics for Dogs and Cats Product
Table 114. Merial Recent Developments/Updates
Table 115. Bayer Animal Health Company Information
Table 116. Bayer Animal Health Description and Business Overview
Table 117. Bayer Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bayer Animal Health Antibiotics for Dogs and Cats Product
Table 119. Bayer Animal Health Recent Developments/Updates
Table 120. Virbac Company Information
Table 121. Virbac Description and Business Overview
Table 122. Virbac Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Virbac Antibiotics for Dogs and Cats Product
Table 124. Virbac Recent Developments/Updates
Table 125. Ceva Company Information
Table 126. Ceva Description and Business Overview
Table 127. Ceva Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Ceva Antibiotics for Dogs and Cats Product
Table 129. Ceva Recent Developments/Updates
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Boehringer Ingelheim Antibiotics for Dogs and Cats Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Vetoquinol Company Information
Table 136. Vetoquinol Description and Business Overview
Table 137. Vetoquinol Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Vetoquinol Antibiotics for Dogs and Cats Product
Table 139. Vetoquinol Recent Developments/Updates
Table 140. Phibro Animal Health Company Information
Table 141. Phibro Animal Health Description and Business Overview
Table 142. Phibro Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Phibro Animal Health Antibiotics for Dogs and Cats Product
Table 144. Phibro Animal Health Recent Developments/Updates
Table 145. NCPC Company Information
Table 146. NCPC Description and Business Overview
Table 147. NCPC Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. NCPC Antibiotics for Dogs and Cats Product
Table 149. NCPC Recent Developments/Updates
Table 150. LKPC Company Information
Table 151. LKPC Description and Business Overview
Table 152. LKPC Antibiotics for Dogs and Cats Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. LKPC Antibiotics for Dogs and Cats Product
Table 154. LKPC Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Antibiotics for Dogs and Cats Distributors List
Table 158. Antibiotics for Dogs and Cats Customers List
Table 159. Antibiotics for Dogs and Cats Market Trends
Table 160. Antibiotics for Dogs and Cats Market Drivers
Table 161. Antibiotics for Dogs and Cats Market Challenges
Table 162. Antibiotics for Dogs and Cats Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antibiotics for Dogs and Cats
Figure 2. Global Antibiotics for Dogs and Cats Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibiotics for Dogs and Cats Market Share by Type: 2024 & 2031
Figure 4. Tetracyclines Product Picture
Figure 5. Penicillins Product Picture
Figure 6. Sulfonamides Product Picture
Figure 7. Macrolides Product Picture
Figure 8. Aminoglycosides Product Picture
Figure 9. Cephalosporins Product Picture
Figure 10. Others Product Picture
Figure 11. Global Antibiotics for Dogs and Cats Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Antibiotics for Dogs and Cats Market Share by Application: 2024 & 2031
Figure 13. Cats
Figure 14. Dogs
Figure 15. Global Antibiotics for Dogs and Cats Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Antibiotics for Dogs and Cats Market Size (2020-2031) & (US$ Million)
Figure 17. Global Antibiotics for Dogs and Cats Sales (2020-2031) & (K Units)
Figure 18. Global Antibiotics for Dogs and Cats Average Price (US$/Unit) & (2020-2031)
Figure 19. Antibiotics for Dogs and Cats Report Years Considered
Figure 20. Antibiotics for Dogs and Cats Sales Share by Manufacturers in 2024
Figure 21. Global Antibiotics for Dogs and Cats Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Antibiotics for Dogs and Cats Players: Market Share by Revenue in Antibiotics for Dogs and Cats in 2024
Figure 23. Antibiotics for Dogs and Cats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Antibiotics for Dogs and Cats Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Antibiotics for Dogs and Cats Sales Market Share by Country (2020-2031)
Figure 26. North America Antibiotics for Dogs and Cats Revenue Market Share by Country (2020-2031)
Figure 27. United States Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Antibiotics for Dogs and Cats Sales Market Share by Country (2020-2031)
Figure 30. Europe Antibiotics for Dogs and Cats Revenue Market Share by Country (2020-2031)
Figure 31. Germany Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Antibiotics for Dogs and Cats Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Antibiotics for Dogs and Cats Revenue Market Share by Region (2020-2031)
Figure 38. China Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Antibiotics for Dogs and Cats Sales Market Share by Country (2020-2031)
Figure 46. Latin America Antibiotics for Dogs and Cats Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Antibiotics for Dogs and Cats Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Antibiotics for Dogs and Cats Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Antibiotics for Dogs and Cats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Antibiotics for Dogs and Cats by Type (2020-2031)
Figure 56. Global Revenue Market Share of Antibiotics for Dogs and Cats by Type (2020-2031)
Figure 57. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Antibiotics for Dogs and Cats by Application (2020-2031)
Figure 59. Global Revenue Market Share of Antibiotics for Dogs and Cats by Application (2020-2031)
Figure 60. Global Antibiotics for Dogs and Cats Price (US$/Unit) by Application (2020-2031)
Figure 61. Antibiotics for Dogs and Cats Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
